WHO, Germany opened Hub for Pandemic and Epidemic Intelligence in Berlin
On Sept. 1, 2021, the World Health Organization inaugurated the new WHO Hub for Pandemic and Epidemic Intelligence…
Quidel announced QuickVueﾮ at-home OTC COVID-19 tests to CVS Pharmacy
On Sept. 1, 2021, Quidel announced it will make Quidelﾒs non-prescription QuickVueﾮ At-Home OTC COVID-19 Test available to…
Moderna announced submission of initial data to U.S. FDA for Its COVID-19 vaccine booster
On Sept. 1, 2021, Moderna announced it had initiated its submission to the U.S. Food and Drug Administration…
Data from phase 2 trial of Fostamatinib in hospitalized COVID-19 patients published in Clinical Infectious Diseases
On Sept. 1, 2021, Rigel Pharma announced the publication of results from a Phase 2 clinical trial evaluating…
World-first agreement between Novartis and NHS enabled broad access to first-in-class cholesterol-lowering medicine
On Aug. 31, 2021, Novartis announced a commercial agreement with the NHS in England as part of a…
Relief reported ZYESAMI(TM) (aviptadil) phase 2b/3 clinical trial demonstrated significant relief from respiratory distress in critical COVID-19
On Aug. 31, 2021, RELIEF THERAPEUTICS reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals…
SK bioscience and GSK started Phase 3 trial of adjuvanted COVID-19 vaccine candidate
On Aug. 31, 2021, SK bioscience and GlaxoSmithKline announced the initiation of a Phase 3 clinical study of…
U.S. Department of Defense announced $194.5 million in industrial base expansion contract awards
On Aug. 31, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
AAXIMﾮ Biotechnologiesﾒ manufacturing partner filed amended EUA for papid COVID-19 neutralizing antibody test
On Aug. 30, 2021, AXIMﾮ Biotechnologies announced that the Companyﾒs manufacturing partner Empowered Diagnostics had filed an amended…
Biotechnology | Disease | Energy | Environmental | Neurology
The United Nations announced the end of leaded gasoline use in vehicles worldwide
On Aug. 30, 2021, the United Nations announced the global phase-out of leaded fuel, a milestone for multilateralism,…
30-year NIAID project revealed structures of infectious prions
On Aug. 30, 2021, after 30 years of steady progress, National Institute of Allergy and Infectious Diseases (NIAID)…
CureVac’s CVnCoV phase 2b/3 study data published in The Lancet
On Aug. 30, 2021, CureVac announced the publication of its pivotal Phase 2b/3 (HERALD study) primary data of…
OPKO Health completed enrollment in phase 2 trial evaluating RAYALDEE as treatment forsymptomatic COVID-19 outpatients
On Aug. 30, 2021, OPKO announced completion of enrollment in its Phase 2 trial with RAYALDEEﾮ as a…
Biotechnology | COVID-19 | NIH | Therapeutics | Vaccine
Oragenics SARS-CoV-2 spike protein produced neutralizing antibodies with Intramuscular and intranasal adjuvants
On Aug. 30, 2021, Oragenics announced that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator…
Monoclonal antibody treatment combo reduced hospitalization among high-risk patients with COVID-19
On Aug. 30, 2021, the Mayo Clinic reported that in an observational study the combination of casirivimab and…
UBC study examines ‘Achilles’ heel’ of cancer tumours, paving the way for new treatment strategies
On Aug. 27, 2021, researchers at University of British Columbia’s (UBC) faculty of medicine and BC Cancer Research…
USDA confirmed COVID-19 in deer in Ohio
On Aug. 27, 2021, the USDA’s National Veterinary Services Laboratories announced confirmation of SARS-CoV-2 (the virus that causes…
Spacestation astronauts successfully demonstrated DNA repair in space using CRISPR technology
On Aug. 27, 2021, National Aeronautics and Space Administration (NASA) Space station astronauts successfully demonstrated DNA repair in…
US Department of Defense awarded $6.5 million contract to U.S. Cotton to increase domestic production of polyester-tipped swabs
On Aug. 27, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
NIH launched study of extra COVID-19 vaccine dose in people with autoimmune disease
On Aug. 27, 2021, The National Institutes of Health announced that it had begun a clinical trial to…
INOVIO received authorization to conduct phase 3 efficacy trial of COVID-19 DNA vaccine candidate, INO-4800 in Brazil
On Aug. 26, 2021, Inovio Pharma announced that it had received regulatory authorization from Brazil’s ANVISA (Agencia Nacional…
Pfizer and BioNTech announced collaboration with Brazil’s Eurofarma to manufacture COVID-19 vaccine doses
On Aug. 26, 2021, Pfizer and BioNTech announced the signing of a letter of intent with Eurofarma Laboratorios,…
Study confirmed virus variants reduce protection against COVID-19
On Aug. 26, 2021, Oregon Health & Science University (OHSU) announced a laboratory study found that blood serum…
University of Nebraska Medical Center team confirmed COVID-19’s airborne transmission in leading scientific journal
On Aug. 26, 2021, the University of Nebraska Medical Center (UNMC) announced findings on airborne transmission have passed…
COVID-19 | Diagnostics | FDA | Medical Device
BD received EUA for first at-home COVID-19 test to use smartphone to interpret, deliver results
On Aug. 25, 2021, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) had issued an…
Johnson & Johnson announced data to support boosting its single-shot COVID-19 vaccine
On Aug. 25, 2021, Johnson & Johnson announced data supporting the use of its COVID-19 vaccine as a…
Pfizer and BioNTech initiated rolling submission of SBLA to U.S. FDA for booster dose of COMIRNATY in individuals 16 and Older
On Aug. 25, 2021, Pfizer and BioNTech announced the initiation of a supplemental Biologics License Application (sBLA) to…
US Department of Defense awarded $14.7 million contract to SteriPack to establish production capability of ExpressCollect collection devices
On Aug. 25, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
Anixa Biosciences’ Covid-19 compounds expected to be effective against the Delta variant
On Aug. 25, 2021, Anixa Biosciences announced that a genomic variant analysis indicateed that its potential compounds may…
Moderna completed submission of BLA to the Food and Drug Administration for its COVID-19 vaccine
On Aug. 25, 2021, Moderna announced it had completed the rolling submission process for its Biologics License Application…